• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于提高细胞转化效率的计算机辅助设计工具。

A computer-guided design tool to increase the efficiency of cellular conversions.

机构信息

Computational Biology Group, CIC bioGUNE-BRTA (Basque Research and Technology Alliance), Bizkaia Technology Park, Derio, Spain.

Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.

出版信息

Nat Commun. 2021 Mar 12;12(1):1659. doi: 10.1038/s41467-021-21801-4.

DOI:10.1038/s41467-021-21801-4
PMID:33712564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7954801/
Abstract

Human cell conversion technology has become an important tool for devising new cell transplantation therapies, generating disease models and testing gene therapies. However, while transcription factor over-expression-based methods have shown great promise in generating cell types in vitro, they often endure low conversion efficiency. In this context, great effort has been devoted to increasing the efficiency of current protocols and the development of computational approaches can be of great help in this endeavor. Here we introduce a computer-guided design tool that combines a computational framework for prioritizing more efficient combinations of instructive factors (IFs) of cellular conversions, called IRENE, with a transposon-based genomic integration system for efficient delivery. Particularly, IRENE relies on a stochastic gene regulatory network model that systematically prioritizes more efficient IFs by maximizing the agreement of the transcriptional and epigenetic landscapes between the converted and target cells. Our predictions substantially increased the efficiency of two established iPSC-differentiation protocols (natural killer cells and melanocytes) and established the first protocol for iPSC-derived mammary epithelial cells with high efficiency.

摘要

人类细胞转化技术已成为设计新的细胞移植疗法、生成疾病模型和测试基因疗法的重要工具。然而,尽管基于转录因子过表达的方法在体外生成细胞类型方面显示出巨大的潜力,但它们通常转化率低。在这种情况下,人们付出了巨大的努力来提高现有方案的效率,而计算方法的发展在这方面可以提供很大的帮助。在这里,我们介绍了一种计算机引导的设计工具,它将一个用于对细胞转化的指令因子(IFs)的更有效组合进行优先级排序的计算框架(称为 IRENE)与一种基于转座子的基因组整合系统结合起来,以实现高效传递。特别是,IRENE 依赖于一个随机基因调控网络模型,该模型通过最大化转化细胞和目标细胞之间的转录和表观遗传景观的一致性,系统地对更有效的 IFs 进行优先级排序。我们的预测大大提高了两种已建立的 iPSC 分化方案(自然杀伤细胞和黑色素细胞)的效率,并建立了第一个高效的 iPSC 衍生的乳腺上皮细胞方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a15/7954801/40eb0ca34225/41467_2021_21801_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a15/7954801/0eeff4caf4c2/41467_2021_21801_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a15/7954801/4b6ea15587ed/41467_2021_21801_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a15/7954801/40eb0ca34225/41467_2021_21801_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a15/7954801/0eeff4caf4c2/41467_2021_21801_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a15/7954801/4b6ea15587ed/41467_2021_21801_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a15/7954801/40eb0ca34225/41467_2021_21801_Fig3_HTML.jpg

相似文献

1
A computer-guided design tool to increase the efficiency of cellular conversions.一种用于提高细胞转化效率的计算机辅助设计工具。
Nat Commun. 2021 Mar 12;12(1):1659. doi: 10.1038/s41467-021-21801-4.
2
A predictive computational framework for direct reprogramming between human cell types.一种用于人类细胞类型之间直接重编程的预测计算框架。
Nat Genet. 2016 Mar;48(3):331-5. doi: 10.1038/ng.3487. Epub 2016 Jan 18.
3
Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34 cells using the auto-erasable Sendai virus vector.使用可自动清除的 Sendai 病毒载体,从患者非动员外周血源性 CD34 细胞中高效生成稳健的 hiPSC。
Stem Cell Res Ther. 2019 Jun 24;10(1):185. doi: 10.1186/s13287-019-1273-2.
4
Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.通过oriP/EBNA-1附加体重编程系统从成纤维细胞和上皮来源的细胞中生成人诱导多能干细胞。
Stem Cell Res Ther. 2015 Jun 19;6(1):122. doi: 10.1186/s13287-015-0112-3.
5
Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.mRNA重编程的人类诱导多能干细胞向视网膜谱系的稳健分化
Stem Cells Transl Med. 2016 Apr;5(4):417-26. doi: 10.5966/sctm.2015-0093. Epub 2016 Mar 1.
6
A site-specific genetic modification for induction of pluripotency and subsequent isolation of derived lung alveolar epithelial type II cells.一种用于诱导多能性和随后分离衍生的肺肺泡上皮细胞 II 型的特定部位的基因修饰。
Stem Cells. 2014 Feb;32(2):402-13. doi: 10.1002/stem.1570.
7
A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.一种新型的泌尿道分化、组织再生和疾病模型:将人类前列腺和膀胱细胞重编程为诱导多能干细胞。
Eur Urol. 2013 Nov;64(5):753-61. doi: 10.1016/j.eururo.2013.03.054. Epub 2013 Apr 6.
8
Quick, Coordinated and Authentic Reprogramming of Ribosome Biogenesis during iPSC Reprogramming.快速、协调和真实的重编程 iPSC 过程中核糖体生物发生。
Cells. 2020 Nov 15;9(11):2484. doi: 10.3390/cells9112484.
9
Computational Analysis of Altering Cell Fate.细胞命运改变的计算分析
Methods Mol Biol. 2019;1975:363-405. doi: 10.1007/978-1-4939-9224-9_17.
10
Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.锌指核酸酶表达杆状病毒载体介导重编程因子基因的靶向基因组整合,以促进人类诱导多能干细胞的产生。
Stem Cells Transl Med. 2013 Dec;2(12):935-45. doi: 10.5966/sctm.2013-0043. Epub 2013 Oct 28.

引用本文的文献

1
Epigenome editing technologies for discovery and medicine.表观基因组编辑技术的发现和医学应用。
Nat Biotechnol. 2024 Aug;42(8):1199-1217. doi: 10.1038/s41587-024-02320-1. Epub 2024 Jul 29.
2
Logical design of synthetic cis-regulatory DNA for genetic tracing of cell identities and state changes.用于细胞身份和状态变化基因追踪的合成顺式调控DNA的逻辑设计。
Nat Commun. 2024 Feb 5;15(1):897. doi: 10.1038/s41467-024-45069-6.
3
Computational methods for biofabrication in tissue engineering and regenerative medicine - a literature review.

本文引用的文献

1
Human melanocyte development and melanoma dedifferentiation at single-cell resolution.单细胞分辨率解析的人类黑素细胞发育与黑色素瘤去分化。
Nat Cell Biol. 2021 Sep;23(9):1035-1047. doi: 10.1038/s41556-021-00740-8. Epub 2021 Sep 2.
2
A comprehensive library of human transcription factors for cell fate engineering.人类转录因子细胞命运工程综合文库。
Nat Biotechnol. 2021 Apr;39(4):510-519. doi: 10.1038/s41587-020-0742-6. Epub 2020 Nov 30.
3
A new view of the mammary epithelial hierarchy and its implications for breast cancer initiation and metastasis.
组织工程与再生医学中生物制造的计算方法——文献综述
Comput Struct Biotechnol J. 2024 Jan 2;23:601-616. doi: 10.1016/j.csbj.2023.12.035. eCollection 2024 Dec.
4
DIRECTEUR: transcriptome-based prediction of small molecules that replace transcription factors for direct cell conversion.基于转录组学的小分子预测,这些小分子可替代转录因子实现细胞的直接转化。
Bioinformatics. 2024 Feb 1;40(2). doi: 10.1093/bioinformatics/btae048.
5
Deciphering driver regulators of cell fate decisions from single-cell transcriptomics data with CEFCON.利用 CEFCON 从单细胞转录组学数据中破译细胞命运决策的驱动调控因子。
Nat Commun. 2023 Dec 20;14(1):8459. doi: 10.1038/s41467-023-44103-3.
6
Programming human cell fate: overcoming challenges and unlocking potential through technological breakthroughs.编程人类细胞命运:通过技术突破克服挑战并释放潜能。
Development. 2023 Dec 15;150(24). doi: 10.1242/dev.202300. Epub 2023 Dec 11.
7
Mechanisms and biotechnological applications of transcription factors.转录因子的作用机制及生物技术应用
Synth Syst Biotechnol. 2023 Aug 31;8(4):565-577. doi: 10.1016/j.synbio.2023.08.006. eCollection 2023 Dec.
8
Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways.人血清可通过重新激活 MAPK 和 EGFR 通路减弱表皮生长因子受体靶向抑制剂对鳞癌细胞生长的抑制作用。
Cells. 2023 Aug 8;12(16):2022. doi: 10.3390/cells12162022.
9
An Optogenetic-Controlled Cell Reprogramming System for Driving Cell Fate and Light-Responsive Chimeric Mice.光遗传学控制的细胞重编程系统用于驱动细胞命运和光响应嵌合小鼠。
Adv Sci (Weinh). 2023 Feb;10(4):e2202858. doi: 10.1002/advs.202202858. Epub 2022 Dec 11.
10
Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition.人血清抑制导管癌细胞BT474生长并调节HER2抑制作用。
Biomedicines. 2022 Aug 8;10(8):1914. doi: 10.3390/biomedicines10081914.
乳腺上皮层级结构的新观点及其对乳腺癌起始和转移的影响。
J Cancer Metastasis Treat. 2019;5. doi: 10.20517/2394-4722.2019.24. Epub 2019 Jun 13.
4
Systematic comparison of single-cell and single-nucleus RNA-sequencing methods.单细胞和单细胞核 RNA 测序方法的系统比较。
Nat Biotechnol. 2020 Jun;38(6):737-746. doi: 10.1038/s41587-020-0465-8. Epub 2020 Apr 6.
5
Small-molecule-mediated reprogramming: a silver lining for regenerative medicine.小分子介导的重编程:再生医学的一线希望。
Exp Mol Med. 2020 Feb;52(2):213-226. doi: 10.1038/s12276-020-0383-3. Epub 2020 Feb 20.
6
EnhancerAtlas 2.0: an updated resource with enhancer annotation in 586 tissue/cell types across nine species.EnhancerAtlas 2.0:一个更新的资源,包含了 9 个物种的 586 种组织/细胞类型中的增强子注释。
Nucleic Acids Res. 2020 Jan 8;48(D1):D58-D64. doi: 10.1093/nar/gkz980.
7
Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.从山中因子组合中去除Oct4可释放诱导多能干细胞的发育潜能。
Cell Stem Cell. 2019 Dec 5;25(6):737-753.e4. doi: 10.1016/j.stem.2019.10.002. Epub 2019 Nov 7.
8
Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation.经慢病毒载体转导共表达 GM-CSF、IFN-α2 和抗原的单核细胞用于干细胞移植前或后急性白血病的个体化免疫治疗。
Cancer Immunol Immunother. 2019 Nov;68(11):1891-1899. doi: 10.1007/s00262-019-02406-9. Epub 2019 Oct 18.
9
Mitigating Antagonism between Transcription and Proliferation Allows Near-Deterministic Cellular Reprogramming.减轻转录与增殖之间的拮抗作用可实现近乎确定性的细胞重编程。
Cell Stem Cell. 2019 Oct 3;25(4):486-500.e9. doi: 10.1016/j.stem.2019.08.005. Epub 2019 Sep 12.
10
Structural Features of Transcription Factors Associating with Nucleosome Binding.与核小体结合相关的转录因子的结构特征
Mol Cell. 2019 Sep 5;75(5):921-932.e6. doi: 10.1016/j.molcel.2019.06.009. Epub 2019 Jul 11.